Literature DB >> 21944030

The role of surgery in metastatic breast cancer.

Jetske Ruiterkamp1, Miranda F Ernst.   

Abstract

Some of the patients who present with breast cancer already have distant metastatic disease. According to recent literature, these patients may benefit from resection of the breast tumour. One explanation for the effect of this resection is that reducing the tumour load influences metastatic growth. Results of future randomised controlled trials should indicate whether surgery of the breast tumour truly improves survival. Selected patients could even benefit from metastasectomy of liver and lung metastases; survival seems to improve and these procedures seldom lead to major complications. When metastasectomy is not possible, minimally invasive techniques can be used in selected patients for the treatment of breast cancer liver metastases, radiofrequency ablation (RFA) being discussed most in the literature. Patients with locally advanced breast cancer are treated multidisciplinarily and with curative intent. Part of the treatment is surgery to reduce tumour load. Regarding treatment of the axilla, in a clinically negative axilla sentinel node biopsy is advised before neoadjuvant treatment; an axillary lymph node dissection is not warranted. In local recurrence, surgery is the primary treatment. Axillary staging can be done in patients with a previous negative sentinel node biopsy. Regional recurrence after breast-conserving surgery or mastectomy is treated with surgery followed by radiotherapy.

Entities:  

Mesh:

Year:  2011        PMID: 21944030     DOI: 10.1016/S0959-8049(11)70142-3

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  26 in total

1.  Surgical resection of a liver metastasis from breast cancer.

Authors:  D Selvakumar; M Dube; P Matey
Journal:  Ann R Coll Surg Engl       Date:  2015-03       Impact factor: 1.891

2.  Is Stereotactic Body Radiotherapy (SBRT) in lymph node oligometastatic patients feasible and effective?

Authors:  Barbara Alicja Jereczek-Fossa; Sara Ronchi; Roberto Orecchia
Journal:  Rep Pract Oncol Radiother       Date:  2014-11-07

3.  Primary 4T1 tumor resection provides critical "window of opportunity" for immunotherapy.

Authors:  Anahit Ghochikyan; Arpine Davtyan; Armine Hovakimyan; Hayk Davtyan; Anna Poghosyan; Alexander Bagaev; Ravshan I Ataullakhanov; Edward L Nelson; Michael G Agadjanyan
Journal:  Clin Exp Metastasis       Date:  2013-10-06       Impact factor: 5.150

4.  Radiofrequency thermal ablation (RFA) of hepatic metastases (METS) from breast cancer (BC): an adjunctive tool in the multimodal treatment of advanced disease.

Authors:  Andrea Veltri; Carlo Gazzera; Monica Barrera; Marco Busso; Federica Solitro; Claudia Filippini; Irene Garetto
Journal:  Radiol Med       Date:  2013-12-03       Impact factor: 3.469

5.  A multicenter, phase II study of epirubicin/cyclophosphamide followed by docetaxel and concurrent trastuzumab as primary systemic therapy for HER-2 positive advanced breast cancer (the HER2NAT study).

Authors:  Kenjiro Aogi; Toshiaki Saeki; Seigo Nakamura; Masahiro Kashiwaba; Nobuaki Sato; Norikazu Masuda; Yoshiaki Rai; Shinji Ohno; Katsumasa Kuroi; Reiki Nishimura; Keiko Miyakoda; Futoshi Akiyama; Masafumi Kurosumi; Tadashi Ikeda
Journal:  Int J Clin Oncol       Date:  2012-07-26       Impact factor: 3.402

Review 6.  Liver resection in selected patients with metastatic breast cancer: a single-centre analysis and review of literature.

Authors:  Y Dittmar; A Altendorf-Hofmann; S Schüle; M Ardelt; O Dirsch; I B Runnebaum; U Settmacher
Journal:  J Cancer Res Clin Oncol       Date:  2013-05-04       Impact factor: 4.553

7.  Management of primary metastatic breast cancer in elderly patients--an international comparison of oncogeriatric versus standard care.

Authors:  Willemien van de Water; Esther Bastiaannet; Kathleen M Egan; Anton J M de Craen; Rudi G J Westendorp; Lodovico Balducci; Cornelis J H van de Velde; Gerrit-Jan Liefers; Martine Extermann
Journal:  J Geriatr Oncol       Date:  2014-03-21       Impact factor: 3.599

8.  DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases.

Authors:  Wilfried Budach; Christiane Matuschek; Edwin Bölke; Jürgen Dunst; Petra Feyer; Rainer Fietkau; Wulf Haase; Wolfgang Harms; Marc D Piroth; Marie-Luise Sautter-Bihl; Felix Sedlmayer; Rainer Souchon; Frederik Wenz; Frederick Wenz; Rolf Sauer
Journal:  Strahlenther Onkol       Date:  2015-05-12       Impact factor: 3.621

9.  Radiofrequency ablation versus hepatic resection for breast cancer liver metastasis: a systematic review and meta-analysis.

Authors:  Yi-Bin Xiao; Bo Zhang; Yu-Lian Wu
Journal:  J Zhejiang Univ Sci B       Date:  2018-11       Impact factor: 3.066

10.  Pathways to breast cancer recurrence.

Authors:  Aamir Ahmad
Journal:  ISRN Oncol       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.